Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Exley

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Journal of Leukocyte Biology|May 19, 2001
CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virusM A Exley, N J Bigley, O Cheng, et al.
Clinical Immunology (Orlando, Fla.)|April 16, 2011
Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramideAndrew E Hogan, Vincent O'Reilly, Margaret R Dunne, et al.
Cancer Immunology, Immunotherapy : CII|May 6, 2022
Invariant NKT cell-augmented GM-CSF-secreting tumor vaccine is effective in advanced prostate cancer modelBindu Varghese, Lydia Lynch, Lianne E Vriend, et al.
European Journal of Immunology|May 22, 2008
Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loopMark A Exley, Runhua Hou, Angela Shaulov, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2015
A Subset of CD8αβ+ Invariant NKT Cells in a Humanized Mouse ModelXiangshu Wen, Seil Kim, Ran Xiong, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2007
Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammalsAnneliese O Speak, Mariolina Salio, David C A Neville, et al.
Immunity|February 24, 2017
Adipose Type One Innate Lymphoid Cells Regulate Macrophage Homeostasis through Targeted CytotoxicitySelma Boulenouar, Xavier Michelet, Danielle Duquette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Generation of antitumor invariant natural killer T cell lines in multiple myeloma and promotion of their functions via lenalidomide: a strategy for immunotherapyWeihua Song, Hans J J van der Vliet, Yu-Tzu Tai, et al.
Immunology|November 25, 2003
Innate immune response to encephalomyocarditis virus infection mediated by CD1dMark A Exley, Nancy J Bigley, Olivia Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancerHans J van der Vliet, Hans J J van der Vliet, Henry B Koon, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Journal of Leukocyte Biology|May 19, 2001
CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virusM A Exley, N J Bigley, O Cheng, et al.
Clinical Immunology (Orlando, Fla.)|April 16, 2011
Activation of human invariant natural killer T cells with a thioglycoside analogue of α-galactosylceramideAndrew E Hogan, Vincent O'Reilly, Margaret R Dunne, et al.
Cancer Immunology, Immunotherapy : CII|May 6, 2022
Invariant NKT cell-augmented GM-CSF-secreting tumor vaccine is effective in advanced prostate cancer modelBindu Varghese, Lydia Lynch, Lianne E Vriend, et al.
European Journal of Immunology|May 22, 2008
Selective activation, expansion, and monitoring of human iNKT cells with a monoclonal antibody specific for the TCR alpha-chain CDR3 loopMark A Exley, Runhua Hou, Angela Shaulov, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2015
A Subset of CD8αβ+ Invariant NKT Cells in a Humanized Mouse ModelXiangshu Wen, Seil Kim, Ran Xiong, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2007
Implications for invariant natural killer T cell ligands due to the restricted presence of isoglobotrihexosylceramide in mammalsAnneliese O Speak, Mariolina Salio, David C A Neville, et al.
Immunity|February 24, 2017
Adipose Type One Innate Lymphoid Cells Regulate Macrophage Homeostasis through Targeted CytotoxicitySelma Boulenouar, Xavier Michelet, Danielle Duquette, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
Generation of antitumor invariant natural killer T cell lines in multiple myeloma and promotion of their functions via lenalidomide: a strategy for immunotherapyWeihua Song, Hans J J van der Vliet, Yu-Tzu Tai, et al.
Immunology|November 25, 2003
Innate immune response to encephalomyocarditis virus infection mediated by CD1dMark A Exley, Nancy J Bigley, Olivia Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 4, 2007
Effects of the administration of high-dose interleukin-2 on immunoregulatory cell subsets in patients with advanced melanoma and renal cell cancerHans J van der Vliet, Hans J J van der Vliet, Henry B Koon, et al.
Pageof 9